Table 1.
Characteristics of study participants at M24
| N or mean + SD | ||
|---|---|---|
| Sex | Male | 106 |
| Female | 287 | |
| Professional category | Nurse/auxiliary/stretcher-bearer | 192 |
| Physician | 93 | |
| Lab technician | 14 | |
| Admin officers/other | 94 | |
| Age | 46.7 ± 11.2 | |
| Comorbidities | Yes | 117 |
| No | 276 | |
| Comorbidity categorya | Cardiovascular | 41 |
| Respiratory disease | 33 | |
| Endocrine | 33 | |
| Gastrointestinal | 12 | |
| Neurological | 10 | |
| Dermatological | 10 | |
| Immunosuppression | 6 | |
| Hematological | 4 | |
| Cancer | 4 | |
| Liver | 3 | |
| Gynecological | 3 | |
| Mental health | 3 | |
| Immunological | 2 | |
| Otherb | 111 | |
| Chronic medicationa | Yes | 92 |
| No | 25 | |
| Smoker | Yes | 79 |
| No | 313 | |
| NA | 1 | |
| No. of people in the household | 2.8 ± 1.3 | |
| Involved in clinical care | Yes | 285 |
| No | 108 | |
| 1st dose vaccination | Pfizer | 251 |
| Moderna | 131 | |
| 2nd dose vaccination | Pfizer | 248 |
| Moderna | 122 | |
| 3rd dose vaccination | Pfizer | 2 |
| Moderna | 285 | |
| Number of doses received | 0 | 11 |
| 1 | 12 | |
| 2 | 83 | |
| 3 | 287 | |
| Breakthrough infection (post M24) | Yes | 109 |
| Among vaccinated with 2 or 3 doses | No | 261 |
aAmong those with comorbidities
bIncludes age-related bone and muscular disorders as well as renal and neuromuscular disorders